Expanding the diversity of mycobacteriophages: Insights into genome architecture and evolution

Autor: Pope, WH, Jacobs-Sera, D, Russel, DA, Peebles, CL, Al-Atrache, Z, Alcoser, TA, Alexander, LM, Alfano, MB, Alford, ST, Amy, NE, Anderson, MD, Anderson, AG, Ang, AAS, Manuel, A, Barber, AJ, Barker, LP, Barrett, JM, Barshop, WD, Bauerle, CM, Bayles, IM, Belfield, KL, Best, AA, Agustin, B, Bowman, CA, Boyer, CA, Bradley, KW, Bradley, VA, Broadway, LN, Budwal, K, Busby, KN, Campbell, IW, Campbell, AM, Carey, A, Caruso, SM, Chew, RD, Cockburn, CL, Cohen, LB, Corajod, JM, Cresawn, SG, Davis, KR, Deng, L, Denver, DR, Dixon, BR, Ekram, S, Elgin, SCR, Engelsen, AE, English, BEV, Erb, ML, Estrada, C, Filliger, LZ, Findley, AM, Forbes, L, Forsyth, MH, Fox, TM, Fritz, MJ, Garcia, R, George, ZD, Georges, AE, Gissendanner, CR, Goff, S, Goldstein, R, Gordon, KC, Green, RD, Guerra, SL, Guiney-Olsen, KR, Guiza, BG, Haghighat, L, Hagopian, GV, Harmon, CJ, Harmson, JS, Hartzog, GA, Harvey, SE, He, S, He, KJ, Healy, KE, Higinbotham, ER, Hildebrandt, EN, Ho, JH, Hogan, GM, Hohenstein, VG, Holz, NA, Huang, VJ, Hufford, EL, Hynes, PM, Jackson, AS, Jansen, EC, Jarvik, J, Jasinto, PG, Jordan, TC, Kasza, T, Katelyn, MA, Kelsey, JS, Kerrigan, LA, Khaw, D, Kim, J, Knutter, JZ, Ko, CC, Larkin, GV, Laroche, JR

Publikováno v: Pope, WH; Jacobs-Sera, D; Russel, DA; Peebles, CL; Al-Atrache, Z; Alcoser, TA; et al.(2011). Expanding the diversity of mycobacteriophages: Insights into genome architecture and evolution. PLoS ONE, 6(1). doi: 10.1371/journal.pone.0016329. UC Santa Cruz: Retrieved from: http://www.escholarship.org/uc/item/57j0g16f

Mycobacteriophages are viruses that infect mycobacterial hosts such as Mycobacterium smegmatis and Mycobacterium tuberculosis. All mycobacteriophages characterized to date are dsDNA tailed phages, and have either siphoviral or myoviral morphotypes. H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::8df9c4c3bc2b8600c6166413e092358a
http://www.escholarship.org/uc/item/57j0g16f

Whole exome sequencing of human papillomavirus-related multiphenotypic sinonasal carcinoma: a case report.

Autor: Cubides-Córdoba MC; Department of Otorhinolaryngology and Head and Neck Surgery, Central University Hospital of Asturias, Oviedo, Spain., Sánchez-Fernández P; Department of Otorhinolaryngology and Head and Neck Surgery, Central University Hospital of Asturias, Oviedo, Spain., Mendoza-Pacas GE; Department of Pathological Anatomy, Central University Hospital of Asturias, Oviedo, Spain., Cabal VN; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, Oviedo, Spain., García-Marín R; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, Oviedo, Spain., Lorenzo-Guerra SL; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, Oviedo, Spain., García-Velasco F; Department of Otorhinolaryngology and Head and Neck Surgery, Son Llàtzer University Hospital, Mallorca, Spain., Hermsen MA; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, Oviedo, Spain., Llorente JL; Department of Otorhinolaryngology and Head and Neck Surgery, Central University Hospital of Asturias, Oviedo, Spain.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Sep 10; Vol. 14, pp. 1448213. Date of Electronic Publication: 2024 Sep 10 (Print Publication: 2024).

Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.

Autor: Lorenzo-Guerra SL; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, 33011 Oviedo, Spain., Codina-Martínez H; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, 33011 Oviedo, Spain., Suárez-Fernández L; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, 33011 Oviedo, Spain., Cabal VN; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, 33011 Oviedo, Spain., García-Marín R; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, 33011 Oviedo, Spain., Riobello C; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, 33011 Oviedo, Spain., Vivanco B; Department of Pathology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., Blanco-Lorenzo V; Department of Pathology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., Sánchez-Fernández P; Department of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., López F; Department of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., Llorente JL; Department of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., Hermsen MA; Department of Head and Neck Cancer, Health Research Institute of the Principality of Asturias, 33011 Oviedo, Spain.

Publikováno v: Cells [Cells] 2023 Dec 30; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 30.

Signaling Pathways mTOR and ERK as Therapeutic Targets in Sinonasal Intestinal-Type Adenocarcinoma.

Autor: Codina-Martínez H; Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain., Lorenzo-Guerra SL; Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain., Cabal VN; Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain., García-Marín R; Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain., Suárez-Fernández L; Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain., Vivanco B; Department of Pathology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., Sánchez-Fernández P; Department of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., López F; Department of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., Llorente JL; Department of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., Hermsen MA; Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 12; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 12.

DNA methylation-based classification of sinonasal tumors.

Autor: Jurmeister P; Institute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany. philipp.jurmeister@med.uni-muenchen.de.; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. philipp.jurmeister@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. philipp.jurmeister@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany. philipp.jurmeister@med.uni-muenchen.de., Glöß S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, Berlin, Germany., Roller R; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Proteomics Platform, Berlin Institute of Health (BIH) and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany., Leitheiser M; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Schmid S; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, Berlin, Germany., Mochmann LH; Institute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany., Payá Capilla E; Institute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany., Fritz R; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Dittmayer C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, Berlin, Germany., Friedrich C; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; MDC Graduate School, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Humboldt Universität zu Berlin, Institute of Chemistry, Berlin, Germany., Thieme A; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, Berlin, Germany., Keyl P; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Jarosch A; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Schallenberg S; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Bläker H; Institute of Pathology, University Hospital Leipzig, Leipzig, Germany., Hoffmann I; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Vollbrecht C; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Lehmann A; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Hummel M; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Heim D; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Haji M; Proteomics Platform, Berlin Institute of Health (BIH) and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany., Harter P; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Neurology (Edinger Institute), Goethe-University Frankfurt am Main, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt am Main, German Cancer Research Center (DKFZ), Heidelberg, Germany., Englert B; Institute of Neuropathology, Ludwig Maximilians University Hospital Munich, Munich, Germany., Frank S; Department of Neuropathology, Institute of Pathology, Basel University Hospital, Basel, Switzerland., Hench J; Department of Neuropathology, Institute of Pathology, Basel University Hospital, Basel, Switzerland., Paulus W; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Hasselblatt M; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Hartmann W; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster, Germany., Dohmen H; Institute of Neuropathology, University of Giessen, Giessen, Germany., Keber U; Institute of Neuropathology, Philipps-University, Marburg, Germany., Jank P; Institute of Pathology, Philipps-University Marburg and University Hospital Marburg, Marburg, Germany., Denkert C; Institute of Pathology, Philipps-University Marburg and University Hospital Marburg, Marburg, Germany., Stadelmann C; Institute for Neuropathology, University Medical Centre Göttingen, Göttingen, Germany., Bremmer F; Institute of Pathology, University Medical Center, Göttingen, Germany., Richter A; Institute of Pathology, University Medical Center, Göttingen, Germany., Wefers A; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ribbat-Idel J; Institute of Pathology, University of Luebeck and University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany., Perner S; Institute of Pathology, University of Luebeck and University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.; Pathology, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.; German Center for Lung Research (DZL), Partner Site Luebeck, Luebeck, Germany., Idel C; Department of Otorhinolaryngology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Chiariotti L; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.; CEINGE Biotecnologie Avanzate, 80145, Naples, Italy., Della Monica R; CEINGE Biotecnologie Avanzate, 80145, Naples, Italy., Marinelli A; Department of Medicina Clinica e Chirurgia, University Federico II, Naples, Italy., Schüller U; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany., Bockmayr M; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany., Liu J; UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.; UCL Academic Head and Neck Centre, Division of Surgery and Interventional Science, University College London, London, UK., Lund VJ; UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.; UCL Academic Head and Neck Centre, Division of Surgery and Interventional Science, University College London, London, UK., Forster M; UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.; UCL Academic Head and Neck Centre, Division of Surgery and Interventional Science, University College London, London, UK., Lechner M; UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.; UCL Academic Head and Neck Centre, Division of Surgery and Interventional Science, University College London, London, UK., Lorenzo-Guerra SL; Department of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain., Hermsen M; Department of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain., Johann PD; Swabian Childrens' Cancer Center, University Childrens' Hospital Augsburg and EU-RHAB Registry, Augsburg, Germany., Agaimy A; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital, Erlangen, Germany., Seegerer P; Machine-Learning Group, Department of Software Engineering and Theoretical Computer Science, Technical University of Berlin, Berlin, Germany., Koch A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, Berlin, Germany., Heppner F; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, Berlin, Germany., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany., Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sill M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany., von Deimling A; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Snuderl M; Division of Neuropathology, NYU Langone Health, New York, USA.; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, USA.; Division of Molecular Pathology and Diagnostics, NYU Langone Health, New York, USA., Müller KR; Machine-Learning Group, Department of Software Engineering and Theoretical Computer Science, Technical University of Berlin, Berlin, Germany.; Department of Artificial Intelligence, Korea University, Seoul, South Korea.; Max-Planck-Institute for Informatics, Saarbrücken, Germany.; BIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany., Forgó E; Stanford University School of Medicine, Stanford, CA, USA., Howitt BE; Stanford University School of Medicine, Stanford, CA, USA., Mertins P; Proteomics Platform, Berlin Institute of Health (BIH) and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany., Klauschen F; Institute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; BIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany., Capper D; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, Berlin, Germany.

Publikováno v: Nature communications [Nat Commun] 2022 Nov 28; Vol. 13 (1), pp. 7148. Date of Electronic Publication: 2022 Nov 28.